Renflexis 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F18PN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,058
Award facts
- Contract value 100% obligated
- $18,058.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order valued at $18,058.06 by the Defense Logistics Agency (DLA) on November 25, 2025, for the supply of Renflexis 100 mg vials. The contract is a firm fixed price delivery order with an ultimate completion date of November 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was utilized for this award, indicating the contract was competitively awarded. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The DLA Medical Supply Chain relies on the company's capability to deliver specialized medications, brand-name and generic drugs, and medical commodities across multiple therapeutic domains to support Defense Health Agency customers and other federal healthcare systems worldwide. The award of this delivery order demonstrates the contractor's continued role in fulfilling the DLA's pharmaceutical procurement requirements under the prime IDV vehicle.
Quick answers
Who was awarded contract SPE2DR26F18PN?
SPE2DR26F18PN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F18PN worth?
The government has obligated $18,058 on SPE2DR26F18PN.
Is contract SPE2DR26F18PN an order under another contract?
Yes. SPE2DR26F18PN is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F18PN competed?
The extent of competition for SPE2DR26F18PN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award